Larson Financial Group LLC Has $181,000 Stock Holdings in Waters Co. (NYSE:WAT)

Larson Financial Group LLC increased its holdings in shares of Waters Co. (NYSE:WATFree Report) by 59.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 503 shares of the medical instruments supplier’s stock after buying an additional 188 shares during the period. Larson Financial Group LLC’s holdings in Waters were worth $181,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. OneDigital Investment Advisors LLC boosted its position in Waters by 3.8% during the 3rd quarter. OneDigital Investment Advisors LLC now owns 851 shares of the medical instruments supplier’s stock worth $306,000 after buying an additional 31 shares during the period. Raymond James Trust N.A. lifted its position in shares of Waters by 2.4% in the 3rd quarter. Raymond James Trust N.A. now owns 1,340 shares of the medical instruments supplier’s stock worth $482,000 after purchasing an additional 32 shares during the period. Linscomb Wealth Inc. lifted its position in shares of Waters by 0.4% in the 2nd quarter. Linscomb Wealth Inc. now owns 7,841 shares of the medical instruments supplier’s stock worth $2,275,000 after purchasing an additional 34 shares during the period. Johnson Investment Counsel Inc. lifted its position in shares of Waters by 3.2% in the 2nd quarter. Johnson Investment Counsel Inc. now owns 1,084 shares of the medical instruments supplier’s stock worth $314,000 after purchasing an additional 34 shares during the period. Finally, Summit Trail Advisors LLC lifted its position in shares of Waters by 3.0% in the 2nd quarter. Summit Trail Advisors LLC now owns 1,170 shares of the medical instruments supplier’s stock worth $339,000 after purchasing an additional 34 shares during the period. 94.01% of the stock is currently owned by institutional investors and hedge funds.

Waters Stock Performance

Shares of WAT stock opened at $386.57 on Thursday. The firm has a market capitalization of $22.95 billion, a PE ratio of 36.89, a price-to-earnings-growth ratio of 6.92 and a beta of 0.97. The firm has a fifty day simple moving average of $356.22 and a two-hundred day simple moving average of $332.60. The company has a current ratio of 2.02, a quick ratio of 1.38 and a debt-to-equity ratio of 1.14. Waters Co. has a 12 month low of $273.60 and a 12 month high of $395.44.

Waters (NYSE:WATGet Free Report) last announced its quarterly earnings results on Friday, November 1st. The medical instruments supplier reported $2.93 EPS for the quarter, beating analysts’ consensus estimates of $2.68 by $0.25. Waters had a net margin of 21.43% and a return on equity of 49.93%. The business had revenue of $740.30 million during the quarter, compared to analyst estimates of $712.99 million. During the same quarter in the previous year, the business posted $2.84 EPS. Waters’s quarterly revenue was up 4.0% on a year-over-year basis. Analysts forecast that Waters Co. will post 11.79 EPS for the current fiscal year.

Analyst Ratings Changes

WAT has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. boosted their price target on shares of Waters from $340.00 to $380.00 and gave the stock a “neutral” rating in a research report on Monday, November 4th. Cfra set a $389.00 price target on shares of Waters in a research report on Thursday, October 17th. TD Cowen boosted their price target on shares of Waters from $363.00 to $410.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Wells Fargo & Company boosted their target price on shares of Waters from $380.00 to $415.00 and gave the company an “overweight” rating in a research report on Monday, November 4th. Finally, Sanford C. Bernstein boosted their target price on shares of Waters from $345.00 to $360.00 and gave the company a “market perform” rating in a research report on Monday, November 4th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating, three have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $365.85.

Read Our Latest Research Report on Waters

Waters Company Profile

(Free Report)

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Read More

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WATFree Report).

Institutional Ownership by Quarter for Waters (NYSE:WAT)

Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.